Dissociation of Infectivity from Seeding Ability in Prions with Alternate Docking Mechanism
Previous studies identified two mammalian prion protein (PrP) polybasic domains that bind the disease-associated conformer PrPSc, suggesting that these domains of cellular prion protein (PrPC) serve as docking sites for PrPSc during prion propagation. To examine the role of polybasic domains in the context of full-length PrPC, we used prion proteins lacking one or both polybasic domains expressed from Chinese hamster ovary (CHO) cells as substrates in serial protein misfolding cyclic amplification (sPMCA) reactions. After ∼5 rounds of sPMCA, PrPSc molecules lacking the central polybasic domain (ΔC) were formed. Surprisingly, in contrast to wild-type prions, ΔC-PrPSc prions could bind to and induce quantitative conversion of all the polybasic domain mutant substrates into PrPSc molecules. Remarkably, ΔC-PrPSc and other polybasic domain PrPSc molecules displayed diminished or absent biological infectivity relative to wild-type PrPSc, despite their ability to seed sPMCA reactions of normal mouse brain homogenate. Thus, ΔC-PrPSc prions interact with PrPC molecules through a novel interaction mechanism, yielding an expanded substrate range and highly efficient PrPSc propagation. Furthermore, polybasic domain deficient PrPSc molecules provide the first example of dissociation between normal brain homogenate sPMCA seeding ability from biological prion infectivity. These results suggest that the propagation of PrPSc molecules may not depend on a single stereotypic mechanism, but that normal PrPC/PrPSc interaction through polybasic domains may be required to generate prion infectivity.
Vyšlo v časopise:
Dissociation of Infectivity from Seeding Ability in Prions with Alternate Docking Mechanism. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002128
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002128
Souhrn
Previous studies identified two mammalian prion protein (PrP) polybasic domains that bind the disease-associated conformer PrPSc, suggesting that these domains of cellular prion protein (PrPC) serve as docking sites for PrPSc during prion propagation. To examine the role of polybasic domains in the context of full-length PrPC, we used prion proteins lacking one or both polybasic domains expressed from Chinese hamster ovary (CHO) cells as substrates in serial protein misfolding cyclic amplification (sPMCA) reactions. After ∼5 rounds of sPMCA, PrPSc molecules lacking the central polybasic domain (ΔC) were formed. Surprisingly, in contrast to wild-type prions, ΔC-PrPSc prions could bind to and induce quantitative conversion of all the polybasic domain mutant substrates into PrPSc molecules. Remarkably, ΔC-PrPSc and other polybasic domain PrPSc molecules displayed diminished or absent biological infectivity relative to wild-type PrPSc, despite their ability to seed sPMCA reactions of normal mouse brain homogenate. Thus, ΔC-PrPSc prions interact with PrPC molecules through a novel interaction mechanism, yielding an expanded substrate range and highly efficient PrPSc propagation. Furthermore, polybasic domain deficient PrPSc molecules provide the first example of dissociation between normal brain homogenate sPMCA seeding ability from biological prion infectivity. These results suggest that the propagation of PrPSc molecules may not depend on a single stereotypic mechanism, but that normal PrPC/PrPSc interaction through polybasic domains may be required to generate prion infectivity.
Zdroje
1. PrusinerSB 1982 Novel proteinaceous infectious particles cause scrapie. Science 216 136 144
2. PrusinerSB 1998 Prions. Proc Natl Acad Sci U S A 95 13363 13383
3. BrandnerSIsenmannSRaeberAFischerMSailerA 1996 Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 339 343
4. BuelerHAguzziASailerAGreinerRAAutenriedP 1993 Mice devoid of PrP are resistant to scrapie. Cell 73 1339 1347
5. OeschBWestawayDWalchliMMcKinleyMPKentSB 1985 A cellular gene encodes scrapie PrP 27–30 protein. Cell 40 735 746
6. MansonJCClarkeARMcBridePAMcConnellIHopeJ 1994 PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3 331 340
7. KociskoDAComeJHPriolaSAChesebroBRaymondGJ 1994 Cell-free formation of protease-resistant prion protein. Nature 370 471 474
8. CastillaJSaaPHetzCSotoC 2005 In vitro generation of infectious scrapie prions. Cell 121 195 206
9. SaaPCastillaJSotoC 2006 Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281 35245 35252
10. MurayamaYYoshiokaMHoriiHTakataMYokoyamaT 2006 Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation. Biochem Biophys Res Commun 348 758 762
11. DeleaultNRHarrisBTReesJRSupattaponeS 2007 Formation of native prions from minimal componenets in vitro. Proc Natl Acad Sci U S A 104 9741 9746
12. WangFWangXYuanCGMaJ 2010 Generating a Prion with Bacterially Expressed Recombinant Prion Protein. Science 327 1132 1135
13. HoriuchiMPriolaSAChabryJCaugheyB 2000 Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proc Natl Acad Sci U S A 97 5836 5841
14. LauALYamAYMichelitschMMWangXGaoC 2007 Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC. Proc Natl Acad Sci U S A 104 11551 11556
15. MoronciniGKanuNSolforosiLAbalosGTellingGC 2004 Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc Natl Acad Sci U S A 101 10404 10409
16. SolforosiLBellonASchallerMCruiteJTAbalosGC 2007 Toward molecular dissection of PrPC-PrPSc interactions. J Biol Chem 282 7465 7471
17. RiekRHornemannSWiderGGlockshuberRWuthrichK 1997 NMR characterization of the full-length recombinant murine prion protein, mPrP(23–231). FEBS Lett 413 282 288
18. ZahnR 2003 The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site. J Mol Biol 334 477 488
19. PeretzDWilliamsonRAKanekoKVergaraJLeclercE 2001 Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 739 743
20. WhiteAREneverPTayebiMMushensRLinehanJ 2003 Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422 80 83
21. WangFYinSWangXZhaLSyMS 2010 Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 49 8169 8176
22. OstapchenkoVGMakaravaNSavtchenkoRBaskakovIV 2008 The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP. J Mol Biol 383 1210 1224
23. SupattaponeSMuramotoTLegnameGMehlhornICohenFE 2001 Identification of two prion protein regions that modify scrapie incubation time. J Virol 75 1408 1413
24. BaumannFTolnayMBrabeckCPahnkeJKlozU 2007 Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 26 538 547
25. LiAChristensenHMStewartLRRothKAChiesaR 2007 Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125. EMBO J 26 548 558
26. ShmerlingDHegyiIFischerMBlattlerTBrandnerS 1998 Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 203 214
27. AbalosGCCruiteJTBellonAHemmersSAkagiJ 2008 Identifying key components of the PrPC-PrPSc replicative interface. J Biol Chem 283 34021 34028
28. MakaravaNBaskakovIV 2008 Expression and purification of full-length recombinant PrP of high purity. Methods Mol Biol 459 131 143
29. GeogheganJCMillerMBKwakAHHarrisBTSupattaponeS 2009 Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog 5 e1000535
30. CastillaJSaaPMoralesRAbidKMaundrellK 2006 Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 412 3 21
31. DeleaultNRKascsakRGeogheganJCSupattaponeS 2010 Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49 3928 3934
32. CastillaJMoralesRSaaPBarriaMGambettiP 2008 Cell-free propagation of prion strains. Embo J 27 2557 2566
33. SaborioGPPermanneBSotoC 2001 Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 810 813
34. ChenBMoralesRBarriaMASotoC 2010 Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods 7 519 520
35. NishinaKADeleaultNRMahalSPBaskakovILuhrsT 2006 The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro. Biochemistry 45 14129 14139
36. CastillaJGonzalez-RomeroDSaaPMoralesRDe CastroJ 2008 Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134 757 768
37. AngersRCKangHENapierDBrowningSSewardT 2010 Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328 1154 1158
38. LiJBrowningSMahalSPOelschlegelAMWeissmannC 2009 Darwinian Evolution of Prions in Cell Culture. Science 327 869 872
39. DePaceAHSantosoAHillnerPWeissmanJS 1998 A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93 1241 1252
40. BrachmannABaxaUWicknerRB 2005 Prion generation in vitro: amyloid of Ure2p is infectious. Embo J 24 3082 3092
41. GloverJRKowalASSchirmerECPatinoMMLiuJJ 1997 Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89 811 819
42. KingCYDiaz-AvalosR 2004 Protein-only transmission of three yeast prion strains. Nature 428 319 323
43. TanakaMChienPNaberNCookeRWeissmanJS 2004 Conformational variations in an infectious protein determine prion strain differences. Nature 428 323 328
44. AbidKMoralesRSotoC 2010 Cellular factors implicated in prion replication. FEBS Lett 584 2409 2414
45. GrahamJFAgarwalSKurianDKirbyLPinheiroTJ 2010 Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 285 9868 9880
46. FischerMRulickeTRaeberASailerAMoserM 1996 Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15 1255 1264
47. SupattaponeSBosquePMuramotoTWilleHAagaardC 1999 Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 96 869 878
48. DeleaultAMDeleaultNRHarrisBTReesJRSupattaponeS 2008 The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 89 2642 2650
49. McKinleyMPBoltonDCPrusinerSB 1983 A protease-resistant protein is a structural component of the scrapie prion. Cell 35 57 62
50. AguibYHeisekeAGilchSRiemerCBaierM 2009 Autophagy induction by trehalose counteracts cellular prion infection. Autophagy 5 361 369
51. EnariMFlechsigEWeissmannC 2001 Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 98 9295 9299
52. LuhrKMNordstromEKLowPLjunggrenHGTaraboulosA 2004 Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells. J Virol 78 4776 4782
53. MohanJHopkinsJMabbottNA 2005 Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure. Immunology 116 122 133
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
Najčítanejšie v tomto čísle
- Requires Glycerol for Maximum Fitness During The Tick Phase of the Enzootic Cycle
- Comparative Genomics Yields Insights into Niche Adaptation of Plant Vascular Wilt Pathogens
- “Persisters”: Survival at the Cellular Level
- The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations